The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Beyond THC and Endocannabinoids
Abstract
Research in the cannabinoid field, namely on phytocannabinoids, the endogenous cannabinoids anandamide and 2-arachidonoyl glycerol and their metabolizing and synthetic enzymes, the cannabinoid receptors, and anandamide-like cannabinoid compounds, has expanded tremendously over the last few years. Numerous endocannabinoid-like compounds have been discovered. The Cannabis plant constituent cannabidiol (CBD) was found to exert beneficial effects in many preclinical disease models ranging from epilepsy, cardiovascular disease, inflammation, and autoimmunity to neurodegenerative and kidney diseases and cancer. CBD was recently approved in the United States for the treatment of rare forms of childhood epilepsy. This has triggered the development of many CBD-based products for human use, often with overstated claims regarding their therapeutic effects. In this article, the recently published research on the chemistry and biological effects of plant cannabinoids (specifically CBD), endocannabinoids, certain long-chain fatty acid amides, and the variety of relevant receptors is critically reviewed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cannabidiol (CBD; Epidolex®) acts as a negative allosteric modulator at CB1 receptors [7] and also acts at several other receptors, such as CB2 receptors, serotonin 1A receptors, opioid receptors and several ligand-gated ion channels [8]”
From Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. (2022) · cites this paper as [8]
Citations
Cites
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Self-citationIsolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Self-citationMolecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Self-citation2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Self-citationHandbook of Experimental Pharmacology.
Meakin, J. W. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.1971.00310230151026 · Cited by 1,959
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
Cited by
Sorted by citations
Items 101–185 of 185
Review of cannabis reimbursement by workers’ compensation insurance in the U.S. and Canada
Howard, J., Wurzelbacher, S. J., Osborne, J. C., Wolf, J., Ruser, J. W., & Chadarevian, R. (2021) · American Journal of Industrial Medicine · doi:10.1002/ajim.23294 · Cited by 5
Effect of combining CBD with standard breast cancer therapeutics
Dobovišek, L., Novak, M., Krstanović, F., Borštnar, S., Turnšek, T. L., & Debeljak, N. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100038 · Cited by 5
Lachenmeier, D. W., & Walch, S. G. (2021) · F1000Research · doi:10.12688/f1000research.26045.2 · Cited by 5
Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells
Boyacıoğlu, Ö., & Korkusuz, P. (2022) · Advances in experimental medicine and biology · doi:10.1007/5584_2022_748 · Cited by 5
A journey through cannabidiol in Parkinson’s disease
Del-Bel, E., Barros, N., de Moraes, R. A. P. D. S., de Mattos, B. A., Alves-Fernandes, T. A., de Abreu, L. B., Nascimento, G. C., Escobar-Espinal, D. M., Pedrazzi, J. F. C., Jacob, G. A., et al. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.015 · Cited by 4
Belbasi, Z., Petr, J., Hrbáč, J., & Jirovský, D. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.116875 · Cited by 4
Esteban, S. R. D. M., Grande, M. T., Martínez-Relimpio, A. M., Herráez‐Aguilar, D., Mostany, R., Hillard, C. J., Hind, W. H., & Romero, J. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118902 · Cited by 4
Potential Protective Effects of Pungent Flavor Components in Neurodegenerative Diseases
Guo, F., Qin, X., Mao, J., Xu, Y. C., & Xie, J. (2024) · Molecules · doi:10.3390/molecules29235700 · Cited by 4
Exploring Natural Analgesics for Chronic Pain Management: Cannabinoids and other Phytoconstituents
Bjørklund, G., Oleshchuk, O., Гонтова, Т. М., Кланца, М. П., Lukanyuk, M. I., Денефіль, О. В., Коshovyi, O., Shanaida, V., & Shanaida, M. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673330732241017135054 · Cited by 4
Zhang, X., Wang, B., Chen, S., & Fu, Y. (2023) · Biomedical Chromatography · doi:10.1002/bmc.5683 · Cited by 4
Endocannabinoid basis of personality—Insights from animal model of social behavior
Kogan, N. M., Begmatova, D., Vinnikova, L., Malitsky, S., Itkin, M., Sharon, E., Klinov, A., Gorelick, J., Koman, I. E., Vogel, Z., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1234332 · Cited by 3
Self-citationHarhangi, M. S., Höfert, L., Danser, A. H. J., Bijma, H. H., Simons, S. S., Reiss, I. K. M., Baumann, S., & Broekhuizen, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031398 · Cited by 3
Krzyżewska, A., Baranowska‐Kuczko, M., & Kozłowska, H. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70347 · Cited by 3
Ye, G., Li, J., Gao, H., Zhou, Z., Liu, M., Li, L., Cifuentes, A., Zhang, Y., & Lu, W. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158043 · Cited by 3
García-Hernández, V. M., Torres-Román, A. L., Ruíz‐García, E., Santamarı́a, A., Manzo-Merino, J., García-López, A., Angélica-Lezama, R., Matus-Santos, J. A., Prospero-Garcia, O. E., Ríos, J. N., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052033 · Cited by 3
Addeo, N. F., Iervolino, V., Amato, R., Lanzieri, M., Lotito, D., Tignani, M. V., Staropoli, A., Damiano, S., Lombardi, P., Vinale, F., et al. (2025) · Veterinary Sciences · doi:10.3390/vetsci12080759 · Cited by 3
Sharkey, K. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821597-5.00003-4 · Cited by 3
Unravelling the Impact: Pulmonary Side Effects of Anti-Seizure Medications
Butera, A., Pirrone, M., Accetta, A. S., Consoli, C., Nicotera, A. G., & Turriziani, L. (2024) · Current Respiratory Medicine Reviews · doi:10.2174/011573398x279958240131101144 · Cited by 3
Clinical effectiveness of medical marijuana in patients with amyotrophic lateral sclerosis
Austin, J. M., Bailey, R. R., Velázquez, S. A. G., Sainath, H., & Jackson, C. E. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123243 · Cited by 3
Neurologic Effects of Drug Abuse
Jain, K. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-73503-6_17 · Cited by 3
Tribute to Professor Raphael Mechoulam, The Founder of Cannabinoid and Endocannabinoid Research
Maccarrone, M. (2022) · Molecules · doi:10.3390/molecules27010323 · Cited by 3
CB65 and novel CB65 liposomal system suppress MG63 and Saos-2 osteosarcoma cell growth in vitro
Zorba, B. I., Boyacıoğlu, Ö., Çağlayan, T., Reçber, T., Nemutlu, E., Eroğlu, İ., & Korkusuz, P. (2023) · Journal of Liposome Research · doi:10.1080/08982104.2023.2262025 · Cited by 2
The endocannabinoid system as a target for the treatment of neurological disorders
DeMesa, J., Appendino, G., Morello, G., Murray, M. P., & Muñóz, E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00002-1 · Cited by 2
Cannabinoids - Recent Perspectives and Applications in Human Health
JAMES, S. P. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100996 · Cited by 2
Ignatowska-Jankowska, B. M., Özer, A. G., Kuck, A., Niphakis, M. J., Ogasawara, D., Cravatt, B. F., & Uusisaari, M. Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.25.546437 · Cited by 2
Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years
Pérez-Morales, M., Espinoza-Abad, R., & García‐García, F. (2025) · Pharmaceuticals · doi:10.3390/ph18020266 · Cited by 1
Síndrome de hiperémesis cannabinoide: una revisión
Jiménez‐Castillo, R. A., Arumugam, S., Remes-Troche, J. M., & Venkatesan, T. (2025) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2025.02.003 · Cited by 1
Nanotechnology for the Efficacious Delivery of Medicinal Cannabis and Pharmaceutical Medicines
Vitetta, L., Henson, J. D., Hayes, E., Rutolo, D., & Hall, S. (2025) · Pharmaceuticals · doi:10.3390/ph18091385 · Cited by 1
Beyond opioids: cannabis and the changing landscape of cancer pain
Khoshjabinzadeh, A., McGinnis, R., Afolabi, Y., & Keniston, L. (2025) · Academia oncology. · doi:10.20935/acadonco7974 · Cited by 1
Strnad, O., Nejedlý, T., Svoboda, P., Mertlíková‐Kaiserová, H., Malý, M., Malý, M., Stranska-Zachariasova, M., & Viktorová, J. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.121134 · Cited by 1
Toward Cannabinoid Use for Refractory Cutaneous Dermatomyositis
Wittmann, M., Staubach, P., & McGonagle, D. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.07.017 · Cited by 1
Kovalenko, I. S., Denisenko, Y., Novgorodtseva, T. P., Bocharova, N. V., & Omatova, U. M. (2022) · Bulletin physiology and pathology of respiration · doi:10.36604/1998-5029-2022-86-129-137 · Cited by 1
Cannabis and Organ Damage: A Focus on Pancreatitis (to Include Different Scenarios)
Saviano, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_68 · Cited by 1
Waltl, L., Holubek, D., Speck, K., Wildermuth, R., Haut, F., Permann, S., Plangger, I., Steinborn, C., Rao, Z., D’Avino, D., et al. (2026) · Advanced Science · doi:10.1002/advs.76861 · Cited by 1
Effect of THC, CBD, THCV, CBC and CBN Cannabinoids on β-Cells Exposed to High Glucose—High LipidsPreprint
Gojani, E. G., Wang, B., Li, D., Kovalchuk, O., & Kovalchuk, I. (2023) · Preprints.org · doi:10.20944/preprints202309.0973.v1 · Cited by 1
Zamarrenho, L. G. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-23082020-104553
Tims, N. (2021) · Lancaster EPrints (Lancaster University) · doi:10.17635/lancaster/thesis/1438
Marzo, V. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-57401-7_186
Neurobiological Mechanisms in Substance Use
Butelman, E. R., & Kreek, M. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-95350-8_2
Marzo, V. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-21573-6_186-1
Cannabis and Organ Damage: A Focus on Pancreatitis (to Include Different Scenarios)
Saviano, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_68-1
Kronusová, O., Piklová, M., Šírová, K., Kronusová, O., Piklová, M., Šírová, K., Kaštánek, P., Kaštánek, P., Gürlich, R., & Braťka, P. (2022) · American Journal of Applied Sciences · doi:10.3844/ajassp.2022.68.77
Grelle, G. M. R. S., Sampaio, L. D. S., & Einicker‐Lamas, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106780
Cannabis for medicinal use in patients with rare diseases
Parovincaka, J., Szijj, J. V., Serracino‐Inglott, A., & Azzopardi, L. M. (2023) · Translational Science of Rare Diseases · doi:10.3233/trd-230060
Laurentiis, A. D., Wolfson, M. L., & Correa, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95698-7.00010-3
Canabinoides: aspectos histórico-culturais, químicos e farmacológicos
da Costa, F. B., Citó, A. M. D. G. L., & Silva, D. D. C. (2023) · doi:10.22533/at.ed.429231912
Zhao, H.-Y., Liang, K., & Fang, Y. (2024) · Theoretical and Natural Science · doi:10.54254/2753-8818/32/20240910
Biological fate of cannabis and its metabolic products
Babu, R., Mohapatra, A., Amarjeet, A., & Garabadu, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15489-8.00004-9
Sampaio, L. D. S., Campos, R. M. P., Karhson, D. S., & Iannotti, F. A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1432892
Medicinal chemistry of cannabinoids
Chimphepo, L., Jana, C. E., Chirambo, G., Mwambyale, T., & Gwedela, M. N. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95927-8.00020-7
Volos, L. I., & Шевчук, Н. Н. (2023) · Azerbajdžanskij medicinskij žurnal · doi:10.34921/amj.2023.4.023
Anandamide: From modulation of neuronal excitation to antimicrobial activities—What is in common?
Sionov, R. V., & Steinberg, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00017-2
Principais alvos farmacológicos e potencial terapêutico do canabidiol (CDB)
de Medeiros, A. B. M., Diniz, L. A. S., de Lira, A. G., Zambrzycki, I. T., Kawalende, S. C. N., Alves, I. D. S., de Andrade, L. O. L., Barbalho, T. M., Matias, A. F., Costa, E. D. S., et al. (2024) · Caderno Pedagógico · doi:10.54033/cadpedv21n9-091
Kumrić, M., Dujić, G., Vrdoljak, J., Šupe‐Domić, D., Dujić, Ž., & Božić, J. (2025) · Cannabis and Cannabinoid Research · doi:10.1177/25785125251392773
García, A. Q., Raïch, I., del Torrent, C. L., Lillo, J., Casajuana-Martín, N., Rebassa, J. B., Navarro, G., & Pardo, L. (2025) · Protein Science · doi:10.1002/pro.70394
Bilbao, A., & Spanagel, R. (2022) · Figshare · doi:10.6084/m9.figshare.20517185
Bilbao, A., & Spanagel, R. (2022) · Figshare · doi:10.6084/m9.figshare.20517173
Bilbao, A., & Spanagel, R. (2022) · Figshare · doi:10.6084/m9.figshare.20517164
Bilbao, A., & Spanagel, R. (2022) · Figshare · doi:10.6084/m9.figshare.20517176
Bilbao, A., & Spanagel, R. (2022) · Figshare · doi:10.6084/m9.figshare.20517179
Bilbao, A., & Spanagel, R. (2022) · Figshare · doi:10.6084/m9.figshare.20517167
Utilização de cannabis sativa L. em doenças neurodegenerativas
Gil, M. R. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Systematic study of Cannabis sativa L: phytochemistry, biological effects and terpene profile
Venkli, D. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
EFFECT OF WATER-DEFICIT STRESS ON CANNABIS SATIVA PRODUCTION AND SECONDARY METABOLITE LEVELS
Sharma, S. (2025) · OpenSIUC (Southern Illinois University Carbondale)
Barreras de acceso al cannabis medicinal en Colombia. Una revisión narrativa
Castaño, G. A., Carrillo, S., & Malagón, R. (2025) · Revista Colombiana de Ciencias Químico Farmacéuticas · doi:10.15446/rcciquifa.v54n1.119551
Delemazure, A., Bayouli, I. T., Deconinck, E., Canfyn, M., Meers, E., & Tack, F. M. G. (2026) · International Journal of Phytoremediation · doi:10.1080/15226514.2026.2643786
Trick or Treat: Unintentional Cannabis Intoxication From Edibles in a Preschool Child—A Case Report
Heiler, E., Wedegärtner, S., Nordhoff, D., Hamelmann, E. H., & Wenglein, J. S. (2026) · Clinical Case Reports · doi:10.1002/ccr3.72412
Couto, M. G. G. D., Grope, A. S. R., Coutinho, G. L. F., Carvalho, L. S., Costa, L. A., Bandeira, J. R. B. V., Pereira, I. M. B., & Tolentino, M. V. C. (2026) · Revista Brasileira de Criminalística · doi:10.15260/rbc.v15i1.1022
Chassagne, J. F. (2023) · theses.fr (ABES) · doi:10.70675/508d7244z2b0fz400eza34ezeec1d1c8be41
Piezo2 mediates cannabidiol-induced analgesia of mechanical allodyniaPreprint
He, Q., Lai, R., Huang, W., Zuo, H., Cao, K., Cai, M., Qian, F., Zhang, Y., & Xiao, B. (2026) · doi:10.65215/ltspreprints.2026.04.22.000197
Reis, J. P. R. T. (2025) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-816791-5.00001-7
Modulation of Respiratory Diseases by the Endocannabinoid System: A Therapeutic Perspective
Qin, S., Shen, S., Chen, X., Yi, P., Fu, B., & Peng, L.-Y. (2026) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70267
Permann, S., Brunner, E., Alsabil, K., Werner, M., Waltl, L., Viault, G., D’Avino, D., Perkowski, B. J., Siller, A., Fritsch, L., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.056
Rodrigues, M. D. L., Mina, T. M. D. C., de Abreu, M. R., da Silva, O., Sapatini, D., & Camargo‐Mathias, M. I. (2026) · Comparative Clinical Pathology · doi:10.1007/s00580-026-03822-x
Graczyk, M., Woroń, J., Białka, S., Dobrogowski, J., Doniec, Z., Gola, W., Kapala, P., Krupa, A. J., Leppert, W., Przeklasa-Muszyńska, A., et al. (2026) · Ból · doi:10.5604/01.3001.0055.8656
Albor-Patiño, D. C., Romero, M., Ramos-Hernández, A., Arana, V. A., Gomez, C. M. M., Álzate, J. A. V., Pacheco‐Londoño, L. C., & Ospina-Castro, M. L. (2026) · Applied Sciences · doi:10.3390/app16199748
Thermodynamic properties and formulations of cbd for release in the gastrointestinal system
Rahmanović, A. (2025) · University of Maribor digital library (University of Maribor)
Thepin, N., Somboonsaksri, P., Lapkrajang, D., Termsaithong, N., Limwichean, S., Jintamethasawat, R., Botta, R., & Ngernsutivorakul, T. (2026) · Talanta · doi:10.1016/j.talanta.2026.130735
Paulin, D. A. (2026) · American Journal of Chemical and Biochemical Engineering · doi:10.11648/j.ajcbe.20261001.12
Selectivity studies of CBDs against CB1 and CB2 using docking approach
Sanchez, B. V., & Zhong, A. (2024) · DigitalCommons@UNO
Fernandes, J. V. A., Tudella, G. C. N., Klostermann, A. U., Menegucci, G., & de Almeida, K. J. S. (2026) · Revue Neurologique · doi:10.1016/j.neurol.2026.10.009
Trojnár, E., Matyas, C., Yokus, B., Haskó, G., Lohoff, F. W., Mechoulam, R., & Pacher, P. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109135
Self-citation
Metadata
- Authors
- Pacher, P., Kogan, N. M., & Mechoulam, R.
- Affiliations
- Laboratory of Cardiovascular Physiology and Tissue Injury and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20852, USA;
- Hebrew University of Jerusalem (IL)
- Venue
- Annual Review of Pharmacology and Toxicology
- Publisher
- Annual Reviews
- Published
- 2020-01-06
- Volume
- 60
- Issue
- 1
- Pages
- 637-659
- ISSN
- 0362-1642 (ISSN-L)
- 1545-4304
- OpenAlex
- W2978528228
- Cited by
- 175
- References
- 168
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 20 · 2023: 32 · 2022: 43 · 2021: 27 · 2020: 20
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Annual Review of Pharmacology and Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- cannabidiol, endocannabinoids, phytocannabinoids, anandamide, 2-arachidonoylglycerol, cannabinoid receptors, epilepsy, neurodegenerative diseases, inflammation, autoimmunity, cardiovascular disease, kidney disease, cancer
- MeSH terms
- Animals, Arachidonic Acids, Cannabinoids, Glycerides, Humans, Dronabinol, Polyunsaturated Alkamides, Cannabinoid Receptor Agonists, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review